Professor Alvaro Cruz from Brazil, member of the GINA board of directors and GINA dissemination and implementation committee with 30 years’ experience caring for patients with asthma, examines the assessment of asthma control and identification of patients at risk.
Recent Posts
- Between-Visit Asthma Symptom Monitoring With a Scalable Digital Intervention: A Randomized Clinical Trial
- Real-Life Effectiveness of Budesonide/Formoterol as Maintenance and Reliever Treatment via the Elpenhaler® Device in Patients with Asthma: The NOTOS Observational Study
- The impact of dosage timing for inhaled corticosteroids in asthma: a randomised three-way crossover trial
- Surfactant proteins levels in asthmatic patients and their correlation with severity of asthma: a systematic review
- BTS/NICE/SIGN guideline for asthma 2024: Diagnosis, monitoring and chronic asthma management. How does this compare to GINA 2024?